Amphastar Pharmaceuticals (AMPH) Cash & Equivalents (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted Cash & Equivalents of $223.6 million for Q2 2026, up 30.82% on a QoQ basis from $170.9 million in Q1 2026, and up 19.14% year-over-year from $187.7 million in Q2 2025.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Cash & Equivalents (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals has reported Cash & Equivalents for 14 years, with the latest figure at $223.6 million in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 19.14% year-over-year to $223.6 million in Q2 2026; TTM through Jun 2026 was $223.6 million, a 19.14% increase from a year earlier, with the FY2025 full-year figure at $170.2 million, up 12.25% from the prior year.
- Cash & Equivalents was $223.6 million for Q2 2026 at Amphastar Pharmaceuticals, up from $170.9 million in the prior quarter.
- The five-year high for Cash & Equivalents was $266.8 million in Q3 2023, with the low at $144.3 million in Q4 2023.
- Average Cash & Equivalents over 5 years is $181.9 million, with a median of $174.6 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Cash & Equivalents soared 69.91% in 2022, then retreated 27.99% in 2024.
- Over 5 years, Cash & Equivalents stood at $156.1 million in 2022, then retreated by 7.56% to $144.3 million in 2023, then advanced by 5.07% to $151.6 million in 2024, then gained by 12.25% to $170.2 million in 2025, then surged by 31.4% to $223.6 million in 2026.
- The last three Cash & Equivalents figures came in at $223.6 million (Q2 2026), $170.9 million (Q1 2026), and $170.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 3.66 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 886.50 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 118.35 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 127.64 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 1.83 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 360.21 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 142.75 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 223.61 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 41.25 Mn |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | 3.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223.61 Mn |
| Mar 31, 2026 | 170.94 Mn |
| Dec 31, 2025 | 170.18 Mn |
| Sep 30, 2025 | 216.27 Mn |
| Jun 30, 2025 | 187.69 Mn |
| Mar 31, 2025 | 182.78 Mn |
| Dec 31, 2024 | 151.61 Mn |
| Sep 30, 2024 | 192.12 Mn |
| Jun 30, 2024 | 189.62 Mn |
| Mar 31, 2024 | 201.15 Mn |
| Dec 31, 2023 | 144.30 Mn |
| Sep 30, 2023 | 266.78 Mn |
| Jun 30, 2023 | 148.60 Mn |
| Mar 31, 2023 | 176.62 Mn |
| Dec 31, 2022 | 156.10 Mn |
| Sep 30, 2022 | 157.24 Mn |
| Jun 30, 2022 | 166.16 Mn |
| Mar 31, 2022 | 172.63 Mn |
| Dec 31, 2021 | 126.35 Mn |
| Sep 30, 2021 | 106.61 Mn |
API Access
Amphastar Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();